Gilead Sciences (GILD) EV to CFO (2009 - 2026)
Gilead Sciences' (GILD) EV to CFO was 11.33 for Q2 2026, down 15.6% from 13.42 a year earlier and down 26.0% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) EV to CFO (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Gilead Sciences' EV to CFO came in at 9.66, down 12.9% year-over-year; for FY2025, it came in at 14.43, up 48.8% from FY2024.
- By year, EV to CFO came in at 9.70 in FY2024 (-17.0%), 11.69 in FY2023 (+5.4%), 11.09 in FY2022 (+49.4%) and 7.43 in FY2021 (-7.6%).
- The Q2 2026 figure ranks as the lowest quarterly EV to CFO since Q4 2024.
- Year over year, EV to CFO gained in five of the last eight quarters, with growth averaging 14.4%.
- The high point for year-over-year EV to CFO in five years was Q1 2023 (growth of 66.6%); the low point was Q1 2022 (a decline of 19.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 15.30 (Q1 2026), 14.43 (Q4 2025) and 13.49 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.33 |
| Mar 31, 2026 | 15.30 |
| Dec 31, 2025 | 14.43 |
| Sep 30, 2025 | 13.49 |
| Jun 30, 2025 | 13.42 |
| Mar 31, 2025 | 12.68 |
| Dec 31, 2024 | 9.70 |
| Sep 30, 2024 | 9.91 |
| Jun 30, 2024 | 11.06 |
| Mar 31, 2024 | 10.20 |
| Dec 31, 2023 | 11.69 |
| Sep 30, 2023 | 10.29 |
| Jun 30, 2023 | 9.40 |
| Mar 31, 2023 | 10.88 |
| Dec 31, 2022 | 11.09 |
| Sep 30, 2022 | 7.38 |
| Jun 30, 2022 | 7.11 |
| Mar 31, 2022 | 6.53 |
| Dec 31, 2021 | 7.43 |
| Sep 30, 2021 | 8.12 |
API Access
Gilead Sciences EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();